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Background: Left atrial appendage (LAA) thrombus is an accepted risk factor for ischemic stroke. Following a lit-
erature review we were unable to identify a study that determined the incidence of ischemic stroke in patients
with a conﬁrmed LAA thrombus. The purpose of this study was to establish the incidence of ischemic stroke in
patients with a LAA thrombus conﬁrmed on trans-oesophageal echocardiography (TOE).
Method: A ten year retrospective single centre study was conducted for the period March 2005 to February 2014
in St. Vincent's University Hospital, Ireland. All TOE studies performed during this period were reviewed. A chart
reviewwas carried out on any patient who had a LAA thrombus, left atrial (LA) thrombus or pre-thrombus state
identiﬁed. Charts were reviewed for documented neurological deﬁcits consistent with ischemic stroke or tran-
sient ischemic attack within six months following TOE study.
Results:Overall 1903 TOE studieswere reviewed. A total of 67 TOE studies detected a LAA thrombus, LA thrombus
or pre-thrombus state. In the days prior to TOE, an ischemic stroke had occurred in two of the patients. Following
detection of thrombus or pre-thrombus state on TOE and optimization of oral anti-coagulation (OAC), no patient
had an ischemic stroke over the subsequent six months.
Conclusion: This is the only study todate that has looked at the incidence of ischemic stroke following a conﬁrmed
LAA thrombus, LA thrombus or pre-thrombus state. This single centre study found low stroke rates over a six
month follow-up period in patients with a conﬁrmed LAA thrombus, LA thrombus or pre-thrombus state and
optimization of OAC. Larger studies would be required to conﬁrm these ﬁndings.© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
At least 15% of ischemic strokes and more than a third of ischemic
strokes in the elderly occur as a result of atrial ﬁbrillation (AF) [1-5]. Pa-
tients with documented AF undergo a cardio-embolic risk stratiﬁcation
to determine their appropriateness for oral anti-coagulation (OAC). Pa-
tients with LAA thrombus are considered high risk for ischemic stroke.
Low stroke rates are reported in patients inwhom the LAAhas been sur-
gically removed [6,7]. However, data from retrospective or observation-
al studies in different patient populations have shown inconsistent
results of surgical LAA occlusion [8]. To our knowledge no study has
looked at the incidence of ischemic stroke following the detection of
LAA thrombus. The purpose of this retrospective study is to determineeliability and freedom from bias
land Ltd. This is an open access articlthe incidence of ischemic stroke over a six month period following a
conﬁrmed diagnosis of LAA thrombus, LA thrombus or pre-thrombus
state.
2. Methods
A ten year retrospective single centre study was conducted for the
periodMarch 2005 to February 2014 in St. Vincent's University Hospital,
Ireland. The study protocol conforms to the ethical guidelines of the
1975 Declaration of Helsinki as reﬂected in a priori approval by the
institution's human research committee. Ethical approval was obtained
from the Hospital Ethics Committee. TOE studies were reviewed
through the cardiac database TOMCAT. A pre-thrombus state was
deﬁned as spontaneous echo contrast together with pulsed Doppler re-
cordings of inﬂow and outﬂow velocities of less than 25 cm per second
in the LAA oriﬁce. In studies in which a LAA thrombus, LA thrombus or
pre-thrombus state was detected, a chart reviewwas carried out. In ad-
dition neurological radiographywas reviewed andwas available to con-
ﬁrm clinical ﬁndings. OAC therapy at the time of diagnosis of thrombus
or pre-thrombus state was noted.e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 2
Percentage of patient and their risk stratiﬁcation for ischemic stroke.
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Between March 2005 and February 2014 a total of 1903 TOE studies
were performed. The indication for TOEwas to ﬁnd a cause for a cardio-
embolic event in 414 studies, to exclude a thrombus prior to a planned
cardio-version in 330 studies and assessment of structural heart disease
in 1159 studies.
The average age of the patients was 62.9 ± 10.8 years. There was a
higher number of male (n = 38) than female patients (n = 29), see
Table 1.
A LAA thrombus, LA thrombus or pre-thrombus state was identiﬁed
in 3.5% (n = 67) of TOE studies. This sub divided into a LAA thrombus
being identiﬁed in 2.7% (n= 51) of studies, a LA thrombus being iden-
tiﬁed in 0.1% (n = 2) of studies, a LAA and LA thrombi together being
identiﬁed in 0.1% (n = 3) of studies and a pre-thrombus state being
identiﬁed in 0.6% (n= 11) of studies.
In the 414 patients undergoing investigation for a cardio-
embolic cause 0.48% (n = 2) had a thrombus or pre-thrombus
state identiﬁed. In the 330 patients undergoing TOE prior to a
planned cardio-version 16% (n = 53) had a thrombus or pre-
thrombus state identiﬁed. In the 1159 undergoing assessment of struc-
tural heart disease 1% (n= 12) had a thrombus or pre-thrombus state
identiﬁed.
A history of AF was identiﬁed in 65 of the 67 patients. One patient
undergoing investigation for a cardio-embolic event and one patient
with mitral valve disease had no documented history of AF.
Twenty ﬁve percent (n = 17) of these AF patients had an indica-
tion for OAC based on co-existing valvular heart disease. In AF
patients without valvular heart disease 19% (n = 13) had a low
ischemic stroke risk based on a CHADS2-VASc score of 0, 7.5% (n = 5)
had a low to moderate ischemic stroke risk based on a CHADS2-VASc
score of 1, 10.4% (n = 7) had a moderate ischemic stroke risk based
on a CHADS2-VASc score of 2, 20.9% (n = 14) had a moderate to high
ischemic stroke risk based on a CHADS2-VASc score of 3 and 13.4%
(n = 9) had a high ischemic stroke risk based on a CHADS2-VASc
score of ≥3, see Table 2.
Only 27 patients were on OAC at the time of TOE. Patients with new
onset AFwere not considered to be on OAC if only commenced on treat-
ment prior to TOE study. OAC was commenced in 38 patients following
the TOE, see Table 3. An increase in INR targets, reinforcement of com-
pliance or a switch to novel OAC was made in 27 patients. One patient
was deemed unsuitable for OAC given complicated liver disease with a
previous bleed secondary to oesophageal varices. One patient declined
OAC due to personal concerns.
Two patients had an ischemic stroke prior to the TOE study. Both pa-
tients were undergoing investigation for a cardio-embolic source of is-
chemic stroke. Neither patient was on OAC at the time. One patient
was noted to go into AF at the time of TOE. The second patient had no
documented arrhythmia or structural heart disease.
No patient had an ischemic stroke in the six-month period following
the TOE study and optimal management of OAC.
Results are summarised in Fig. 1.Table 1
The gender and age distribution of patients with a LA thrombus, LAA thrombus or pre
thrombus state.
Male Female
Age b64 65–74 N75 b64 65–74 N75
LAA thrombus 18 9 3 8 9 4
LA thrombus 1 1 0 0 0 0
LAA and LA thrombus 1 1 0 1 0 0
Pre-thrombus 4 0 1 5 1 0
Total 24 10 4 14 10 5
Abbreviations: LAA = left atrial appendage and LA = left atrial.4. Discussion
There is increasing interest in the ﬁeld of cardio-embolic risk strati-
ﬁcation in patients with AF and appropriate introduction of OAC.
Although LAA thrombus is a well accepted risk factor for ischemic
stroke, we were unable to ﬁnd the incidence of ischemic stroke in pa-
tients with a conﬁrmed LAA thrombus on literature review. We there-
fore carried out a retrospective study to determine the occurrence of
ischemic stroke in patients following identiﬁcation of a LAA thrombus
and optimization of OAC in our own centre.
In 2 of our 67 patients AF had not been detected. It is possible that
these 2 patients who developed LAA thrombus in the setting of “sinus
rhythm” and normal cardiac anatomy had paroxysmal AF that had not
been captured clinically. In non-valvular AF thrombus has a tendency
to form in the LAA [7]. Thrombus may dislodge, embolize and lead to is-
chemic stroke [7 and 9]. LAA thrombus is infrequent in sinus rhythm. If
it occurs in sinus rhythm it is typically associated with mitral valve dis-
ease or LA dysfunction [1]. Neither of these 2 patients had mitral valve
disease. Sanna et al. recently reported paroxysmal AF detection rates
(lasting N30 s) in 12.9% of patients with a diagnosis of cryptogenic
stroke over a 12-month period following the index event, using im-
plantable loop recorders [10].
A history of AF was documented in 65 of the 67 patients. The occur-
rence of thrombus or pre-thrombus was 0.48% in patients undergoing
TOE following a cardio-embolic event, 16% in patients undergoing TOE
prior to a planned cardio-version for AF and 1% in patients undergoing
assessment of structural heart disease.
In the 65 AF patients 25% (n=17) had valvular heart disease, 34.3%
had moderate to high risk of ischemic stroke based on a CHADS2-VASc
score of ≥3 and 17.9% had low to moderate risk of ischemic stroke
based on a CHADS2-VASc score of 1 to 2. Interestingly 19.4% (n = 13)
of AF patients had no valvular heart disease and a CHADS2-VASc score
of 0 and therefore would have been deemed by clinical criteria to be
of low risk prior to TOE and identiﬁcation of thrombus.
Only 28 of the 67 patients had an indication for OAC prior to identi-
ﬁcation of thrombus or pre-thrombus state on TOE or new onset AF.Table 3
OAC status before and after diagnosis of LAA thrombus, LA thrombus or pre-thrombus
state.
OAC pre TOE OAC post TOE
LAA thrombus 21 50
LA thrombus 1 2
LAA and LA thrombus 2 3
Pre-thrombus 3 10
Total 27 65
Footnote: LAA = left atrial appendage; LA = left atrial and OAC = oral anti-coagulation.
Footnote:: LAA= left atrial appendage; LA= left atrial and CVA= ischemic cerebrovascular events.
Fig. 1. Flow chart of indication for TOE reviewed and result of study. Footnote: LAA = left atrial appendage; LA = left atrial and CVA = ischemic cerebrovascular events.
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dergoing TOE to exclude thrombus prior to the planned cardio-version.
Our study found a low rate (0 of 67) of ischemic strokes in patients
following a conﬁrmed LA thrombus, LAA thrombus or pre-thrombus
state and introduction or adjustment of OAC. Only 2 patients had a
prior ischemic stroke, and neither patient was on OAC at the time of
their ischemic stroke.
Some series have reported a low stroke rate in patients in whom the
LAA has been surgically removed. Notably, these patients were convert-
ed to sinus rhythm at the time of excision [12,13]. However, data from
retrospective or observational studies in different patient populations
have shown inconsistent results of surgical LAA occlusion [6-8]. More
recently interventional techniques have been developed for percutane-
ous occlusion of the LAA to reduce ischemic stroke [11-13] however,
these devices have not yet been approved in the US and the current
ESC guidelines reﬂect ongoing concerns regarding LAA occlusion [14].
Our ﬁndings of a low rate of clinical thromboembolic events in patients
in whom a thrombus or pre-thrombus state is identiﬁed and subse-
quently OAC optimally controlled are interesting. Larger studies would
be required to verify these results. If conﬁrmed a strategy of medical
management could be justiﬁed without emergent surgical or percuta-
neous intervention in this acute setting.
4.1. Limitations
This single centre study was retrospective and the number of
patients in whom thrombus or pre-thrombus was only 67. Given the
small sample size furthermulticentre studieswould be required to con-
ﬁrm our results. In addition the detection of neurological events was re-
liant not only on retrospective documentation, but also on patient's
reporting of symptoms at follow-up visits. In the absence of symptoms,
neurological imaging is not routinely obtained on patients following a
documented LAA thrombus, and we therefore cannot out rule silent
(sub-clinical) embolic events.
5. Conclusion
This is the only study to date that has looked at the occurrence of
ischemic neurological events in patients following a conﬁrmed LAAthrombus, LA thrombus or pre-thrombus state and subsequent optimi-
zation of OAC. This study found a low rate (0 of 67 patients) of clinical
thromboembolic events. Larger studies would be required to verify
these results. If conﬁrmed this might suggest that a strategy of medical
management is appropriate without emergent surgical or percutaneous
intervention in this acute setting.
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